Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Fiore-Gartland

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Plos One|December 24, 2019
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccinationJacob A Cram, Andrew J Fiore-Gartland, Sujatha Srinivasan, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
Nature|June 22, 2017
Quantifiable predictive features define epitope-specific T cell receptor repertoiresPradyot Dash, Andrew J Fiore-Gartland, Tomer Hertz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trialsMichal Juraska, Craig A Magaret, Jason Shao, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Science Advances|February 13, 2026
Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral bloodPuneet Rawat, Melanie R Shapiro, Leeana D Peters, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Plos One|November 18, 2017
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120Allan C deCamp, Morgane Rolland, Paul T Edlefsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos One|December 24, 2019
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccinationJacob A Cram, Andrew J Fiore-Gartland, Sujatha Srinivasan, et al.
Scientific Reports|January 12, 2018
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine TrialsPreetha Balasubramanian, Constance Williams, Mariya B Shapiro, et al.
The Journal of Infectious Diseases|August 22, 2023
An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine TrialsPhilip C Hill, Frank Cobelens, Leonardo Martinez, et al.
Nature|June 22, 2017
Quantifiable predictive features define epitope-specific T cell receptor repertoiresPradyot Dash, Andrew J Fiore-Gartland, Tomer Hertz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trialsMichal Juraska, Craig A Magaret, Jason Shao, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Science Advances|February 13, 2026
Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral bloodPuneet Rawat, Melanie R Shapiro, Leeana D Peters, et al.
The Lancet. Microbe|December 22, 2024
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant dataPuck T Pelzer, Logan Stuck, Leonardo Martinez, et al.
Plos One|November 18, 2017
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120Allan C deCamp, Morgane Rolland, Paul T Edlefsen, et al.
Pageof 1